Skip to Content

LE20-02

Main Content

Association between PRO and the social transcriptome profile as a predictor of clinical outcomes following hematopoietic cell transplantation.

Study #: LE20-02

Study Status: Published

Presentation(s)

2022, ASH (Oral)
2023, Tandem (Poster)

Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: A CIBMTR analysis.

Citation

Taylor MR, Cole SW, Strom J, Brazauskas R, Baker KS, Phelan R, Buchbinder D, Hamilton B, Schoemans H, Shaw BE, Sharma A, Bhatt NS, Badawy SM, Winestone LE, Preussler JM, Mayo S, Jamani K, Nishihori T, Lee MA, Knight JM.

Blood Advances. 2023, Nov 28: 7(22): 7(22):6830-6838. doi: 10.1182/bloodadvances.2023010746. Epub 2023, Sep 29. PMCID:PMC10679811.

PubMed

PMID: 37773924

Abstract